
Am J Psychiatry 130:67-72, January 1973
doi: 10.1176/appi.ajp.130.1.67
© 1973 American Psychiatric Association
|
|  | |
|
Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness
ROBERT M. POST M.D.,
JOEL KOTIN M.D.1,
FREDERICK K. GOODWIN M.D., , and
EDNA K. GORDON
1 Assistant Adjunct Professor of Psychiatry and Human Behavior, University of California at Irvine, Calif.
In order to evaluate the effect of psychomotor activity on CSF amine metabolites, lumbar punctures were performed after moderately depressed patients had simulated manic hyperactivity for four hours. The CSF levels of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were significantly higher after simulated mania or exercise alone than in the same patients after bed rest. In addition, there was a trend for levels of 3-methoxy-4-hydroxyphenylglycol to increase with activity. The levels of 5-HIAA and HVA correlated with the amount of motor activity: lowest in depression, intermediate in mania and hypomania, and highest in simulated mania. Both metabolites were higher in severe mania than in hypomania. These results suggest that psychomotor activity is an important determinant of CSF amine metabolite levels in affective illness.
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Pasco, L. J. Williams, F. N. Jacka, F. Ng, M. J. Henry, G. C. Nicholson, M. A. Kotowicz, and M. Berk
Tobacco smoking as a risk factor for major depressive disorder: population-based study
The British Journal of Psychiatry,
October 1, 2008;
193(4):
322 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Meyer, H. E. McNeely, S. Sagrati, A. Boovariwala, K. Martin, N. P. L.G. Verhoeff, A. A. Wilson, and S. Houle
Elevated Putamen D2 Receptor Binding Potential in Major Depression With Motor Retardation: An [11C]Raclopride Positron Emission Tomography Study
Am J Psychiatry,
September 1, 2006;
163(9):
1594 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Taylor, G. E. Bruder, J. W. Stewart, P. J. McGrath, J. Halperin, H. Ehrlichman, and F. M. Quitkin
Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients
Am J Psychiatry,
January 1, 2006;
163(1):
73 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Broocks, B. Bandelow, G. Pekrun, A. George, T. Meyer, U. Bartmann, U. Hillmer-Vogel, and E. Rüther
Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder
Am J Psychiatry,
May 1, 1998;
155(5):
603 - 609.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. X. Castellanos
Toward a Pathophysiology of Attention-Deficit/Hyperactivint Disorder
Clinical Pediatrics,
July 1, 1997;
36(7):
381 - 393.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koslow and I. Butler
Biogenic amine synthesis defect in dihydropteridine reductase deficiency
Science,
November 4, 1977;
198(4316):
522 - 523.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Post, E. K. Gordon, F. K. Goodwin, and W. E. Bunney Jr.
Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid
Science,
March 9, 1973;
179(4077):
1002 - 1003.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1973
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|